The global demand for Viscosupplementation Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022-2028.
Viscosupplementation is a treatment procedure for osteoarthritis. Here a gel-like fluid called hyaluronic acid injected into the knee joint acts as a lubricant. This injection facilitates smooth movement of knee joints and reduces swelling or pain around the knee. Hyaluronic acid acts as a shock absorber for loads at the joint and improves knee function. Viscosupplementation does not reverse the arthritic process or re-grow cartilages and is highly effective if the arthritis is in its early stages. This treatment is considered for patients trying to delay getting surgery on the joint. It can be used to treat some instances of rheumatoid arthritis as well.
Market Dynamics
The increased preference for nonsurgical procedures for long-lasting pain relief and mobility restoration in osteoarthritis patients will be the few essential elements favoring this market's growth. The emergence of lifestyle-induced disorders and a significant rise in the demand for proper treatment and cure among people of all income groups will further propel market growth. High investments in the healthcare industry to enable easy access to available diagnosis and treatment options will boost the market growth. A rise in the number of specialized orthopedic clinics and ambulatory surgical centers will be a market booster. The lack of clinical evidence on viscosupplementation's effectiveness and safety continues to hamper this market's growth.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each segment in the global market of viscosupplementation.
Market Segmentation
This section of the viscosupplementation market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.
By Product
- Single Injection
- Three Injection
- Five Injection
By End-use Outlook
- Hospitals
- Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for Viscosupplementation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Viscosupplementation Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the viscosupplementation market include Sanofi, Anika Therapeutics, Inc., Seikagaku Corporation, Zimmer Holdings Inc., Bioventus, Ferring B.V., Lifecore Biomedical, LLC, and LG Life Sciences Ltd.S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.